With over 20 years in neuro-intervention, Chloe developed stroke referral programs across Europe, Asia, and Latin America for Covidien and Medtronic. She later led the European commercial team at Neuravi through its acquisition by J&J and is passionate about developing new markets to help patients with neurovascular disease.

Brendan is a specialized stent engineer with profound knowledge of difficult geometries and underlying pathologies. He brought Neuravi’s Embotrap, Embotrap II, and Nimbus from concept to commercialisation, and applies his passion for groundbreaking technology to solving complex neurovascular challenges.

A Clinician Founder and major international leader in neurovascular medicine, Tommy served as Principal Investigator for landmark trials including ARISE II. As a pioneer who held the first stroke referral course in Europe, he brings deep clinical insight to Ceroflo, ensuring technology addresses the critical, unmet challenges of intracranial disease.

Acting as Financial Advisor, Hugh is a Chartered Accountant with extensive senior management experience in medical device startups. He previously served as CFO of Mainstay Medical, where he oversaw a dual listing IPO on Euronext Paris and the ESM in Dublin along with multiple funding rounds.

A visionairy entrepreneur with a history of winning in the neurovascular space, Eamon co-founded Mednova and Neuravi, leading both to major acquisitions by Abbott and J&J respectively. With a wealth of experience from senior roles at Bard and Medtronic, he guides Ceroflo’s vision of translating deep technical expertise into simple, safer solutions.

A Clinician Founder and major international leader in neurovascular medicine, Tommy served as Principal Investigator for landmark trials including ARISE II. As a pioneer who held the first stroke referral course in Europe, he brings deep clinical insight to Ceroflo, ensuring technology addresses the critical, unmet challenges of intracranial disease.

John brings a wealth of experience from senior positions at Puritan Bennett, Respironics and Medtronic, and from founding medical technology companies like Crospon. A veteran engineer, he applies his deep track record of scaling technologies and successfully exiting to major multinationals to Ceroflo’s mission of safer stroke intervention.

A Clinician Founder and globally recognized interventional neurologist, Leonard is a Senior Consultant at the National University Hospital Singapore. With over 300 publications and leadership roles in major trials like ESCAPE-NEXT, he applies his deep clinical expertise to guide Ceroflo’s mission of safer, more effective stroke intervention.

A Clinician Founder and Consultant Interventional Neuroradiologist at Barts Health, Paul established the BRAIN Conference and serves as an Associate Editor for Interventional Neuroradiology. He applies his clinical and academic expertise to guide Ceroflo in developing next-generation stroke interventions.